TLR3 Serves as a Prognostic Biomarker and Associates with Immune Infiltration in the Renal Clear Cell Carcinoma Microenvironment

Table 2

Correlation of TLR3 expression and the prognosis of KIRC with different clinicopathological factors (Kaplan–Meier plotter).

Pathological parameters	Overall survival
	N	Hazard ratio	value
Stage status
1	398	0.6 (0.33–1.09)	0.088
2	183	0.11 (0.01–0.84)	0.01
3	332	0.47 (0.26–0.84)	0.0093
4	188	0.38 (0.22–0.67)	5e^−4
Gender
Female	284	0.36 (0.21–0.62)	9.5e^−5
Male	948	0.39 (0.26–0.56)	3e^−7
Race
White	690	0.41 (0.3–0.57)	1.1e^−8
Asian	8	NA	NA
Black/African-American	111	0.27 (0.06–1.25)	0.073
Tumor grade
1	14	NA	NA
2	340	0.6 (0.31–1.16)	0.12
3	585	0.33 (0.2–0.53)	2.1e^−6
4	174	0.4 (0.22–0.71)	0.0013
Mutation burden
High	246	0.41 (0.23–0.72)	0.0015
Low	437	0.34 (0.15–0.74)	0.0042